The Tisch Cancer Institute

  1. Home
2 doctors

Research

Cancer Clinical Investigation
Cancer Immunology
Cancer Mechanisms
Cancer Prevention and Control

Research

The Tisch Cancer Institute is a National Cancer Institute Designated Cancer Center with a mission to accelerate the prevention and treatment of cancer, improving the lives of cancer patients and their families in our diverse communities. To this end, The Tisch Cancer Institute has cultivated collaborative research programs that aim to translate discoveries into new therapies and develop novel prevention and care delivery strategies. We continually give priority to cancers that most affect the patient communities of our catchment area.

With key funding through our National Cancer Institute Cancer Center Support Grant, the Institute fosters a dynamic team of scientists, clinical investigators, and administrators, all of whom create the research infrastructure needed to spur new cancer breakthroughs.

Funding Opportunities

Through our annual Developmental Fund Awards, The Tisch Cancer Institute provides support for pilot projects focused on translational and collaborative research between our cancer research programs.

An independent, dedicated Developmental Fund Award Committee oversees the selection process. On an annual basis, the request for application is created by the Institute’s Developmental Fund Award Committee Chair, Stuart Aaronson, MD, and emailed to current Institute members. The awards support translational and/or epidemiological projects that represent inter- and intra-collaborations between members of The Tisch Cancer Institute, with a requirement that the co-principal investigators of the projects are Institute members.

Prior to a project account being established, the project must comply with internal and regulatory approval processes. Scientific progress is monitored through a mid-year progress report, which is reviewed by the Committee Chair, and a final report is required. No-cost extensions can be requested, but justification is required.  

Find A Clinical Trial Make a Gift Discover Careers

Research Programs

Cancer Clinical Investigation

The Cancer Clinical Investigation Program develops new treatment approaches to cancer by translating discoveries into therapeutic trials.

Cancer Immunology

The Cancer Immunology Program identifies mechanisms underlying the suppression of anti-tumor immunity in order to inform the development of effective immunotherapies.

Cancer Mechanisms

The Cancer Mechanisms Program aims to better understand the biology of cancer cell development and proliferation, and to identify therapeutics that target biological pathways.

Cancer Prevention and Control

The Cancer Prevention and Control Program works to reduce the burden of cancer incidence, mortality, and disparities in cancer risks and outcomes.

The Tisch Cancer Institute 2024 Developmental Fund Awardees

Cathie Pfleger and Julie Schnur

Cathie Pfleger, PhD (Cancer Mechanisms) and Julie Schnur, PhD (Cancer Prevention and Control)

Drosophila models of Aromatase Inhibitor-induced Musculoskeletal Pain (AI-MSP)

Carousel Background Image 2

Cathie Pfleger, PhD (Cancer Mechanisms) and Julie Schnur, PhD (Cancer Prevention and Control)

Drosophila models of Aromatase Inhibitor-induced Musculoskeletal Pain (AI-MSP)

Carousel Background Image 2

Jose Javier Bravo-Cordero, PhD (Cancer Mechanisms) and Lucas Ferrari de Andrade, PhD (Cancer Immunology)

Regulation of breast cancer metastatic dormancy by sensory neurons and NK cells

Cathie Pfleger and Julie Schnur

Cathie Pfleger, PhD (Cancer Mechanisms) and Julie Schnur, PhD (Cancer Prevention and Control)

Drosophila models of Aromatase Inhibitor-induced Musculoskeletal Pain (AI-MSP)

Jose Javier Bravo-Cordero and Lucas Ferrari de Andrade

Jose Javier Bravo-Cordero, PhD (Cancer Mechanisms) and Lucas Ferrari de Andrade, PhD (Cancer Immunology)

Regulation of breast cancer metastatic dormancy by sensory neurons and NK cells

David Mulholland and John Sfakianos

David Mulholland, PhD (Cancer Mechanisms) and John Sfakianos, MD (Cancer Clinical Investigation)

Sensitizing Bladder Cancer to Enfortumab Vedotin (EV) by Targeting WNTb-Catenin Signaling

Discover the Latest

Researcher using microscope
2025-02-13 00:00:00.0
Mount Sinai-Led Study Suggests Common Cancer Treatment Does Not Work Well for Hospitalized Patients
Read More
Treatment resistance
2025-02-12 00:00:00.0
Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment
Read More
Test tubes
2025-01-23 00:00:00.0
New Mount Sinai Trial Reveals Major Advance in Treatment of Aggressive Lymphoma
Read More
Doctor adjusting microscope
2025-01-09 00:00:00.0
Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study
Read More
REsearcher using computer
2025-01-06 00:00:00.0
Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy
Read More
Doctor adjusting microscope
2024-12-18 00:00:00.0
Mount Sinai Study Reveals Immune-Modulatory Mechanism of Lurbinectedin in Small-Cell Lung Cancer
Read More
Dubin Gala
2024-12-16 00:00:00.0
Dubin Breast Center Annual Gala at Ziegfeld Ballroom Raises $3.8 Million
Read More
Wagenblast
2024-12-11 00:00:00.0
Mount Sinai’s Elvin Wagenblast Honored by Leukemia & Lymphoma Society for Advancing Research in Childhood Leukemia
Read More

Resources For You

Cancer Centers of Excellence
Patient Care
Oncological Sciences
Division of Hematology and Medical Oncology
Residencies and Fellowships
Shared Resources

Contact Us

The Tisch Cancer Institute

One Gustave L. Levy Place

Box 1128

New York, NY 10029-6574

Christine Ponder, PhD, MPA
Director, Research Administration

Email

Patient Information
The Clinical Research Support Unit

212-824-7391
Email